Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $339.50 USD
Change Today +12.52 / 3.83%
Volume 4.1M
AGN On Other Exchanges
New York
As of 8:04 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul M. Bisaro

Executive Chairman, Allergan plc
AgeTotal Calculated CompensationThis person is connected to 55 board members in 6 different organizations across 10 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Paul M. Bisaro has been the Executive Chairman of Actavis plc since July 2014. Mr. Bisaro served as Chief Executive Officer and President of Actavis plc from September 4, 2007 to July 2014, its Chairman of the Board from October 2013 to July 2014. He served as the Chief Executive Officer, President and Chairman at Actavis Limited since October 2013. He served as the President and Chief Operating Officer of Teva Branded Pharmaceutical Products R&D, Inc. (fromerly, ...

Read Full Background

Corporate Headquarters*

Morris Corporate Center III
Parsippany, New Jersey 07054

United States

Phone: 862-261-7000
Fax: --

Board Members Memberships*

Independent Director
Executive Chairman
Independent Director, Member of Compensation & Management Development Committee and Member of Corporate Governance Committee
Chairman, Chief Executive Officer and President


Bachelor's Degree 1983
University of Michigan
JD 1989
Catholic University of America

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,025,000

Stock Options*

Restricted Stock Awards$25,641,217
All Other Compensation$123,137
Unexercisable Options78,029
Total Number of Options78,029

Total Compensation*

Total Annual Cash Compensation$3,847,950
Total Short Term Compensation$1,025,000
Other Long Term Compensation$25,764,354
Total Calculated Compensation$35,890,666
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGN:US $339.50 USD +12.52


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
Lars Rebien Sørensen Chief Executive Officer, President and Member of Executive Management
Novo Nordisk A/S
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLERGAN PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at